Ozempic & Desire: The Unexpected Psychological Side Effects

The Shifting Landscape of Desire: Ozempic and the Psychology of ‘Moderation’

Ozempic, initially developed as a diabetes medication, has gained widespread attention for its effectiveness in weight management. But a growing body of observation, and now research, suggests a more subtle, and potentially complex, effect: a dampening of desire itself. A recent article in The New Yorker highlights this under-discussed bio-psychological side effect of GLP-1 drugs, framing them as “moderation molecules” that can reduce cravings for everything from food to alcohol. This raises fundamental questions about the nature of desire, its role in mental wellbeing, and the potential consequences of artificially diminishing it.

Beyond Cravings: A ‘Desire Dampener’

GLP-1 medications like semaglutide, the active ingredient in Ozempic, work by mimicking a natural hormone that regulates appetite and blood sugar. However, anecdotal reports and emerging clinical observations suggest the impact extends beyond simply curbing cravings. As Sarah Kawasaki at Penn State Health points out, intervening with desire is a complex undertaking. These drugs may not differentiate between healthy and unhealthy desires, potentially leading to a generalized reduction in motivation and interest. Some individuals report decreased libido, diminished enthusiasm for hobbies, or a general sense of emotional flatness. This “alter ego” of the moderation molecule – a “desire dampener” – can, according to reporting in The New Yorker, “go too far.”

The Problem with a Lack of Desire

From a psychotherapeutic perspective, a life characterized by diminished desire presents a unique set of challenges. Standard screening tools for depression already assess levels of motivation and interest. A core symptom of depression is often anhedonia – the inability to experience pleasure or find enjoyment in activities once considered rewarding. For many, the goal of therapy isn’t simply to eliminate unwanted desires, but to rekindle those that have been lost. As a psychotherapist, the prospect of further diminishing desire feels counterintuitive. many clients actively seek ways to reconnect with passions and drives that have become dormant.

Unpacking ‘Substitutive Desire’

The impact of Ozempic and similar drugs may also reveal underlying patterns of “substitutive desire.” Many compulsive behaviors – overeating, substance abuse, excessive shopping – often serve as coping mechanisms for deeper, unresolved emotional needs. These behaviors become substitutes for healthier ways of managing stress, trauma, or loneliness. For example, someone who grew up in a chaotic household might have turned to food for comfort, creating a strong psychological association between eating and emotional regulation. Therapy can help individuals explore these underlying drivers and develop more adaptive coping strategies.

By reducing the physiological urge to engage in these behaviors, GLP-1 drugs may create space for individuals to confront these underlying issues. Without the immediate distraction of cravings, it becomes possible to gain insight into the root causes of compulsive behavior and address them directly. This can be a powerful therapeutic opportunity, fostering a more nuanced understanding of the self and one’s motivations. However, it’s also possible that dampening desire could simply mask these underlying issues, rather than resolving them.

The Moralization of Desire and the Victorian Echo

The current discourse surrounding Ozempic and weight loss often reflects a broader cultural tendency to moralize desire. Urges are framed as “bad” or “problematic,” and acting on them is often seen as a sign of weakness or lack of self-control. This echoes a Victorian sensibility that valued restraint, moderation, and self-discipline above all else. Succumbing to biological impulses was often viewed as a moral failing. This perspective is amplified by online rhetoric, which frequently promotes messages of self-mastery and strength, often with gendered undertones.

While there’s a degree of truth to the idea that self-control can be beneficial, it’s important to avoid pathologizing desire altogether. As Freud observed with his concept of sublimation, drives can be redirected into socially acceptable and even productive channels. A fascination with gore, for example, might be channeled into a career in surgery, or an obsessive focus on food could be transformed into a passion for nutrition and healthy eating. The danger lies in viewing desire as inherently negative, rather than as a fundamental aspect of the human experience.

The Illusion of a Frictionless Life

the appeal of drugs like Ozempic may stem from a deeper fantasy: the desire for a life without friction, where urges no longer demand constant negotiation. A life where the biological self is tamed, and the individual appears smooth, optimized, and free from contradiction. But is this truly the kind of person we seek to be – or the kind of person we want to connect with? The pursuit of a frictionless existence may come at the cost of vitality, passion, and the very qualities that make life meaningful.

The long-term psychological effects of widespread GLP-1 use remain to be seen. Ongoing research, including clinical trials exploring the use of these drugs for addiction treatment, will be crucial in understanding the full scope of their impact. The New Yorker Radio Hour recently featured a discussion with Dhruv Khullar, who reported on the potential of these drugs for treating addiction, and the implications for our understanding of addiction itself. As we continue to explore the potential benefits and risks of these medications, it’s essential to approach them with caution, recognizing that tampering with the complex system of human desire is not without its consequences.

What comes next: Researchers are actively investigating the neurological mechanisms underlying the effects of GLP-1 drugs on desire and motivation. Further studies are needed to determine whether these effects are sustained over the long term and whether they vary depending on individual factors. Clinicians should carefully assess patients’ psychological wellbeing before and during treatment with GLP-1 medications, and be prepared to address any emerging concerns about diminished desire or motivation.